Are you Dr. Hussain?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 22 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5400 Gibson Blvd SE
Albuquerque, NM 87108Phone+1 505-262-7000Fax+1 505-727-9276
Summary
- Dr. Sanaa Hussain, MD is a board certified pathologist in Albuquerque, New Mexico. She is currently licensed to practice medicine in New Mexico, Oregon, and Pennsylvania. She is affiliated with Providence Portland Medical Center, Providence St. Vincent Medical Center, and Providence Hood River Memorial Hospital.
Education & Training
- Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 2003 - 2004
- University of Illinois College of Medicine at ChicagoResidency, Pathology-Anatomic and Clinical, 1999 - 2003
- Damascus University Faculty of MedicineClass of 1986
Certifications & Licensure
- CA State Medical License 2002 - 2026
- OR State Medical License 2008 - 2025
- NM State Medical License 2005 - 2012
- PA State Medical License 2005 - 2012
- IL State Medical License 1999 - 2003
- American Board of Pathology Pathology - Anatomic
Publications & Presentations
PubMed
- 184 citationsGlobal Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16/CDKN2A Deletion as Prognostic Factors and Critical Evaluation of Mi...Fernando López-Ríos, Shannon Chuai, Raja M. Flores, Shigeki Shimizu, Takatoshi Ohno
Cancer Research. 2006-03-15 - 8 citationsRegarding American College of Surgeons Commission on Cancer Non-Small Cell Lung Cancer Quality of Care Measure 10RLNJohn R. Handy, Kimberly E Costas, Steven Nisco, Raymond Schaerf, Eric Vallières
The Annals of Thoracic Surgery. 2016-10-01 - 36 citationsMorphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib.Maureen F. Zakowski, Sanaa Hussain, William Pao, Marc Ladanyi, Michelle S. Ginsberg
Archives of Pathology & Laboratory Medicine. 2009-10-01